Not Yet Recruiting
Study to Evaluate the Safety and Efficacy of ARI0002h, for the Initial Treatment of Patients With Primary Plasma Cell Leukaemia
NCT06830733
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Hospital Marqués de Valdecilla Santander, Cantabria, Spain
- Clínica Universitaria de Navarra Madrid, Spain
- Hospital 12 de Octubre Madrid, Spain
- Hospital Universitario Virgen de la Arrixaca Murcia, Spain